ArticleFrontiers in cellular and infection microbiology2022

Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in

Maurício T Nascimento et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.